BIO Stock Overview
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
BIOTON S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł3.88 |
| 52 Week High | zł4.10 |
| 52 Week Low | zł3.26 |
| Beta | 0.16 |
| 1 Month Change | -2.39% |
| 3 Month Change | 6.90% |
| 1 Year Change | 6.75% |
| 3 Year Change | -8.82% |
| 5 Year Change | -32.61% |
| Change since IPO | -96.85% |
Recent News & Updates
Shareholder Returns
| BIO | PL Biotechs | PL Market | |
|---|---|---|---|
| 7D | -1.6% | -4.1% | -1.1% |
| 1Y | 6.7% | 3.0% | 27.2% |
Return vs Industry: BIO exceeded the Polish Biotechs industry which returned 3% over the past year.
Return vs Market: BIO underperformed the Polish Market which returned 27.2% over the past year.
Price Volatility
| BIO volatility | |
|---|---|
| BIO Average Weekly Movement | 2.4% |
| Biotechs Industry Average Movement | 4.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 10.1% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: BIO is less volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: BIO's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 357 | Jeremy Launders | https://www.bioton.pl |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A. Fundamentals Summary
| BIO fundamental statistics | |
|---|---|
| Market Cap | zł332.72m |
| Earnings (TTM) | zł4.38m |
| Revenue (TTM) | zł218.48m |
76.0x
P/E Ratio1.5x
P/S RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIO income statement (TTM) | |
|---|---|
| Revenue | zł218.48m |
| Cost of Revenue | zł123.94m |
| Gross Profit | zł94.54m |
| Other Expenses | zł90.16m |
| Earnings | zł4.38m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Oct 31, 2023
| Earnings per share (EPS) | 0.051 |
| Gross Margin | 43.27% |
| Net Profit Margin | 2.00% |
| Debt/Equity Ratio | 10.4% |
How did BIO perform over the long term?
See historical performance and comparison